Decatecholaminisation of Septic Shock With Dexmedetomidine and In-hospital Mortality
Status:
Not yet recruiting
Trial end date:
2022-09-01
Target enrollment:
Participant gender:
Summary
The study aims to determine whether the infusion of DEX in septic shock can reduce
in-hospital mortality, norepinephrine infusion, need and duration for mechanical ventilation,
and acute kidney injury without significant adverse events.